Tied Tube Trial in Glaucoma Surgery
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Washington University School of Medicine
- Study ID
- NCT05685485
- Status
- Recruiting
Conditions
- Ahmed Glaucoma Valve Implantation
- Glaucoma Eye
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Standard Implantation — PROCEDURETraditional Ahmed plantation without vicryl ligature
- Tied off Tube — PROCEDUREAhmed implantation with vicryl ligature
Study Details
The aim of this study is to assess whether delaying early flow through the Ahmed tube shunt may improve the post-operative surgical outcomes and provide a more predictable outcome. To assess this the investigator will conduct a, randomized prospective, multi-centered study with collaborators at WashU in St. Louis, Duke University, Indiana University and the University of Pittsburgh. Participants will be randomized to have an AGV placement with tube ligation (no-early flow) and without ligation (allowing for early flow). IOP will be measured at day one, week one, and months, one, three six, and twelve. Additionally, clinical data regarding number of glaucoma medications, and complications post-operative complications will also be collected.
Key Dates
- Start date
- Oct 18, 2022
- Status verified
- Aug 2024
- Primary completion
- Dec 18, 2024
- Completion
- Jan 31, 2025
Study Design
- Enrollment
- 152 participants (estimated)
Arms
- Arm: Standard ImplantationStandard Implantation
- Arm: Tied off TubeTied off Tube
Primary Outcome Measure
IOP Change [ Time Frame: Months 1, 3 , 6, and 12 ]
Central Contacts
- Amer Al Badwai314-286-2946
- Eve Adcock314-273-3557
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Washington University | St Louis | Missouri | 63108 | James Liu, MD (PRINCIPAL_INVESTIGATOR) Carla Siegfried, MD (SUB_INVESTIGATOR) Erin Sieck, MD (SUB_INVESTIGATOR) Arsham Sheybani, MD (SUB_INVESTIGATOR) |